BRACAnalysis^®

BRACAnalysis is test that looks for mutations in the BRCA1 and BRCA2 genes with a result available within 21 working days.

People who carry a mutation have a predisposition to develop breast cancer, ovarian cancer and prostate cancer, as well as other cancers and have a 50% chance of passing this mutation onto each of their children.

People who may benefit from the BRACAnalysis include; those with a personal and/or family history of breast and ovarian cancer, those with early onset of breast cancer prior to age 50 and women of Ashkenazi Jewish descent.

For more information, please contact an Opaldia team member on 020 7554 4052.